Omeprazole (A2845): Technical Guidance for Research Use

What This Product Solves

Omeprazole, chemically identified as 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide, is a well-characterized H+,K+-ATPase inhibitor. Its primary application is in controlled laboratory models of gastric acid secretion and antiulcer activity, supporting studies of peptic ulcer disease and related gastric acid-related disorders. The compound's well-defined IC₅₀ values for H+,K+-ATPase inhibition and histamine-induced acid formation (Omeprazole) are essential for establishing reproducible pharmacological endpoints. This product provides a consistent, high-purity standard for mechanistic studies, dose–response experiments, and assay development. Researchers should not use Omeprazole (A2845) for diagnostic or medical purposes.

For additional context on mechanistic applications and best practices in gastric acid secretion research, see the internal article here, which discusses assay selection and compound benchmarking. Another reference, Omeprazole (A2845): Protocol Guidance for H+,K+-ATPase Inhibition, details protocol recommendations and caveats for laboratory workflows.

Protocol Parameters

• Assay: H+,K+-ATPase inhibition
  Value: IC₅₀ = 5.8 μM
  Applicability: Benchmark for standard in vitro inhibition studies.
  Rationale: Defines the concentration at which 50% enzyme inhibition is achieved, guiding dose–response setup.
  Source type: product information
• Assay: Histamine-induced gastric acid formation
  Value: IC₅₀ = 0.16 μM
  Applicability: Suitable for cellular models of acid secretion.
  Rationale: Supports titration protocols for antiulcer activity study in relevant cell-based assays.
  Source type: product information
• Assay: Solubility in DMSO
  Value: ≥17.27 mg/mL
  Applicability: Preparation of concentrated stock solutions for in vitro workflows.
  Rationale: Ensures adequate solubilization for serial dilution and minimizes precipitation risk.
  Source type: product information
• Assay: Storage as solid at -20°C
  Value: Recommended
  Applicability: Preserves compound integrity for long-term use.
  Rationale: Prevents hydrolysis and degradation that compromise experimental reproducibility.
  Source type: product information

Workflow Setup and QC Checklist

For reliable results in gastric acid secretion research and antiulcer activity studies, consider the following workflow and quality control recommendations:

• Stock Preparation: Dissolve Omeprazole in DMSO at concentrations ≤17.27 mg/mL. Avoid water and ethanol due to insolubility.
• Aliquoting: Prepare single-use aliquots to minimize freeze-thaw cycles and DMSO exposure.
• Storage: Store the solid compound at -20°C. Do not store Omeprazole solution long-term; make fresh working solutions for each experiment.
• Shipping: Upon receipt, verify the package was shipped on blue ice and inspect for condensation or temperature excursions.
• Purity Confirmation: Confirm approximately 98% purity via vendor documentation or in-house analytical QC if available.
• Controls: Include appropriate negative and positive controls within each experimental batch to confirm specificity of H+,K+-ATPase inhibition.
• Documentation: Record batch numbers, preparation dates, and experimental conditions for traceability and reproducibility.

Common Failure Modes and Fixes

• Precipitation in Solution: If visible precipitate forms, check DMSO concentration and ensure solution is freshly prepared. Use vortexing and brief sonication if necessary.
• Loss of Activity: Decreased inhibitory effect may result from prolonged solution storage at room temperature or repeated freeze-thaw cycles. Always prepare fresh working aliquots before use.
• Batch-to-Batch Variability: If experimental results differ between lots, review purity certificates and storage history. Standardize protocols across experiments and use consistent compound sources.
• Inconsistent Dose–Response: Validate pipetting accuracy for serial dilutions and check for compound adsorption to plasticware.
• Assay Interference: Monitor for DMSO effects in cell-based assays and use matched vehicle controls.

Scope and Limitations

Omeprazole (A2845) is validated for in vitro and select ex vivo research applications related to gastric acid secretion, antiulcer activity, and peptic ulcer disease models. It is not formulated or approved for animal studies requiring clinical dosing, diagnostic procedures, or any therapeutic use. Solubility is limited to DMSO, and the compound is not compatible with aqueous or ethanol-based systems. Long-term stability is only established for the solid form at -20°C; solution stability is not guaranteed and should be managed accordingly. Researchers must verify all workflow adaptations in pilot assays before scaling protocols.

Conclusion

Omeprazole (SKU A2845) offers a robust, high-purity option for controlled H+,K+-ATPase inhibition in gastric acid secretion and antiulcer research workflows. Adhering to recommended storage, handling, and assay protocols ensures experimental reliability and reproducibility. For additional mechanistic context or troubleshooting guidance, researchers are encouraged to review internal articles linked above or consult the Omeprazole product page from APExBIO. This product is strictly intended for scientific research and should not be repurposed for any clinical or diagnostic applications.